News

News

Media Contact

    • 24 October 2016
    • Rosen Quoted on Obstacles to Generic EpiPen

    • Partner David Rosen participated in a question and answer session with Reuter’s Westlaw, “Q&A: Foley & Lardner’s David Rosen on Obstacles to Generic EpiPen,” on October 24, 2106.
    Filters applied:
    Search phrase entered: